Management of patients with persistent β-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy
Objectives: To show that the β-human chorionic gonadotropin (hCG) decline following tubal-preserving techniques for ectopic pregnancy (EP) can take a longer course than currently believed, indicating expectant management; and to define the indications for a second-look laparoscopy if β-hCG persists....
Gespeichert in:
Veröffentlicht in: | International journal of gynecology and obstetrics 1994-10, Vol.47 (1), p.33-38 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 38 |
---|---|
container_issue | 1 |
container_start_page | 33 |
container_title | International journal of gynecology and obstetrics |
container_volume | 47 |
creator | Bonatz, G. Lehmann-Willenbrock, E. Kunstmann, P. Semm, I. Hedderich, J. Semm, K. |
description | Objectives: To show that the β-human chorionic gonadotropin (hCG) decline following tubal-preserving techniques for ectopic pregnancy (EP) can take a longer course than currently believed, indicating expectant management; and to define the indications for a second-look laparoscopy if β-hCG persists.
Methods: Three hundred thirty-seven patients treated for EP were retrospectively reviewed. In order to define the ‘normal’ β-hCG decline following tubal-preserving techniques we acquired a Kaplan-Meier curve for 98 patients treated by laparoscopic linear salpingotomy, the main method performed for EP (253 patients). The Mann-Whitney U-test served as a statistical test. The patient population requiring a second-look laparoscopy for proliferating trophoblastic remnants is described.
Results: Twenty-eight patients (8.3%) required a second-look laparoscopy (acute abdominal pain and sonographically suspect findings combined with increasing β-hCG values). The majority (15 patients) underwent a preceding laparoscopic linear salpingotomy (6.5% unresolved cases). The relative β-hCG values differed significantly from the unresolved group compared to the group with resolved EP starting at postoperative day 2 (
P < 0.01). A maximal β-hCG decline period of 77 days postoperatively was observed.
Conclusions: Patients with slowly declining β-hCG levels following tubal-preserving techniques for EP can be managed expectantly. Increasing β-hCG values combined with abdominal pain and sonographically suspect observations indicate a second-look laparoscopy. |
doi_str_mv | 10.1016/0020-7292(94)90458-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76925294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0020729294904588</els_id><sourcerecordid>76925294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4353-6a2f98a6c1759b85adc0a3f725d36695e7ec35a063b1cfeabd47a0dba71165ce3</originalsourceid><addsrcrecordid>eNqNkcGO0zAURS0EGkrhD0DyAiFYBOzEieMNEqqgDBo0G1hbL85LxsiNg51M1TV_xIfwTTht1SVi5Sfde9_TPSbkOWdvOePVO8Zylslc5a-VeKOYKOusfkBWvJYqK4RUD8nqYnlMnsT4gzHGJedX5EqWueJKrcivrzBAjzscJuo7OsJk0xjp3k53dMQQbZwW7c_v7G6zpffgZoy08875vR166mCE4KPxozU0zqG3BhyFoaXOL1Mb5p5OAWE6nuh8oGimo3sM2A8wmMNT8qgDF_HZ-V2T758-ftt8zm5ut9ebDzeZEUVZZBXknaqhMlyWqqlLaA2DopN52RZVpUqUaIoSWFU03HQITSsksLaBVLkqDRZr8uq0dwz-Z6ox6Z2NBp2DAf0ctaxUnriIZBQno0nVYsBOj8HuIBw0Z3phrxewegGrldBH9rpOsRfn_XOzw_YSOsNO-suzDjGx6UIqb-PFJnIhZCq6JvXJtrcOD_91Wl9_2d4WRYq-P0UxYby3GHQ06T8NtjYk7Lr19t8V_gI1v7RW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76925294</pqid></control><display><type>article</type><title>Management of patients with persistent β-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elsevier ScienceDirect Journals</source><creator>Bonatz, G. ; Lehmann-Willenbrock, E. ; Kunstmann, P. ; Semm, I. ; Hedderich, J. ; Semm, K.</creator><creatorcontrib>Bonatz, G. ; Lehmann-Willenbrock, E. ; Kunstmann, P. ; Semm, I. ; Hedderich, J. ; Semm, K.</creatorcontrib><description>Objectives: To show that the β-human chorionic gonadotropin (hCG) decline following tubal-preserving techniques for ectopic pregnancy (EP) can take a longer course than currently believed, indicating expectant management; and to define the indications for a second-look laparoscopy if β-hCG persists.
Methods: Three hundred thirty-seven patients treated for EP were retrospectively reviewed. In order to define the ‘normal’ β-hCG decline following tubal-preserving techniques we acquired a Kaplan-Meier curve for 98 patients treated by laparoscopic linear salpingotomy, the main method performed for EP (253 patients). The Mann-Whitney U-test served as a statistical test. The patient population requiring a second-look laparoscopy for proliferating trophoblastic remnants is described.
Results: Twenty-eight patients (8.3%) required a second-look laparoscopy (acute abdominal pain and sonographically suspect findings combined with increasing β-hCG values). The majority (15 patients) underwent a preceding laparoscopic linear salpingotomy (6.5% unresolved cases). The relative β-hCG values differed significantly from the unresolved group compared to the group with resolved EP starting at postoperative day 2 (
P < 0.01). A maximal β-hCG decline period of 77 days postoperatively was observed.
Conclusions: Patients with slowly declining β-hCG levels following tubal-preserving techniques for EP can be managed expectantly. Increasing β-hCG values combined with abdominal pain and sonographically suspect observations indicate a second-look laparoscopy.</description><identifier>ISSN: 0020-7292</identifier><identifier>EISSN: 1879-3479</identifier><identifier>DOI: 10.1016/0020-7292(94)90458-8</identifier><identifier>PMID: 7529199</identifier><identifier>CODEN: IJGOAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Biological and medical sciences ; Chorionic Gonadotropin - blood ; Chorionic Gonadotropin, beta Subunit, Human ; Diseases of mother, fetus and pregnancy ; Ectopic pregnancy ; Female ; Follow-Up Studies ; Gynecology. Andrology. Obstetrics ; Humans ; Laparoscopy ; Local drug instillation ; Medical sciences ; Methotrexate - therapeutic use ; Minimal invasive surgery ; Ornipressin - therapeutic use ; Peptide Fragments - blood ; Pregnancy ; Pregnancy, Tubal - blood ; Pregnancy, Tubal - epidemiology ; Pregnancy, Tubal - therapy ; Pregnancy. Fetus. Placenta ; Reoperation ; Retrospective Studies ; Time Factors ; Tubal-preserving treatment ; β-hCG persistence</subject><ispartof>International journal of gynecology and obstetrics, 1994-10, Vol.47 (1), p.33-38</ispartof><rights>1994</rights><rights>1994 International Federation of Gynecology and Obstetrics</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4353-6a2f98a6c1759b85adc0a3f725d36695e7ec35a063b1cfeabd47a0dba71165ce3</citedby><cites>FETCH-LOGICAL-c4353-6a2f98a6c1759b85adc0a3f725d36695e7ec35a063b1cfeabd47a0dba71165ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2F0020-7292%2894%2990458-8$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0020729294904588$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,1411,3536,27903,27904,45553,45554,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4244735$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7529199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bonatz, G.</creatorcontrib><creatorcontrib>Lehmann-Willenbrock, E.</creatorcontrib><creatorcontrib>Kunstmann, P.</creatorcontrib><creatorcontrib>Semm, I.</creatorcontrib><creatorcontrib>Hedderich, J.</creatorcontrib><creatorcontrib>Semm, K.</creatorcontrib><title>Management of patients with persistent β-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy</title><title>International journal of gynecology and obstetrics</title><addtitle>Int J Gynaecol Obstet</addtitle><description>Objectives: To show that the β-human chorionic gonadotropin (hCG) decline following tubal-preserving techniques for ectopic pregnancy (EP) can take a longer course than currently believed, indicating expectant management; and to define the indications for a second-look laparoscopy if β-hCG persists.
Methods: Three hundred thirty-seven patients treated for EP were retrospectively reviewed. In order to define the ‘normal’ β-hCG decline following tubal-preserving techniques we acquired a Kaplan-Meier curve for 98 patients treated by laparoscopic linear salpingotomy, the main method performed for EP (253 patients). The Mann-Whitney U-test served as a statistical test. The patient population requiring a second-look laparoscopy for proliferating trophoblastic remnants is described.
Results: Twenty-eight patients (8.3%) required a second-look laparoscopy (acute abdominal pain and sonographically suspect findings combined with increasing β-hCG values). The majority (15 patients) underwent a preceding laparoscopic linear salpingotomy (6.5% unresolved cases). The relative β-hCG values differed significantly from the unresolved group compared to the group with resolved EP starting at postoperative day 2 (
P < 0.01). A maximal β-hCG decline period of 77 days postoperatively was observed.
Conclusions: Patients with slowly declining β-hCG levels following tubal-preserving techniques for EP can be managed expectantly. Increasing β-hCG values combined with abdominal pain and sonographically suspect observations indicate a second-look laparoscopy.</description><subject>Biological and medical sciences</subject><subject>Chorionic Gonadotropin - blood</subject><subject>Chorionic Gonadotropin, beta Subunit, Human</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Ectopic pregnancy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Laparoscopy</subject><subject>Local drug instillation</subject><subject>Medical sciences</subject><subject>Methotrexate - therapeutic use</subject><subject>Minimal invasive surgery</subject><subject>Ornipressin - therapeutic use</subject><subject>Peptide Fragments - blood</subject><subject>Pregnancy</subject><subject>Pregnancy, Tubal - blood</subject><subject>Pregnancy, Tubal - epidemiology</subject><subject>Pregnancy, Tubal - therapy</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Reoperation</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>Tubal-preserving treatment</subject><subject>β-hCG persistence</subject><issn>0020-7292</issn><issn>1879-3479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcGO0zAURS0EGkrhD0DyAiFYBOzEieMNEqqgDBo0G1hbL85LxsiNg51M1TV_xIfwTTht1SVi5Sfde9_TPSbkOWdvOePVO8Zylslc5a-VeKOYKOusfkBWvJYqK4RUD8nqYnlMnsT4gzHGJedX5EqWueJKrcivrzBAjzscJuo7OsJk0xjp3k53dMQQbZwW7c_v7G6zpffgZoy08875vR166mCE4KPxozU0zqG3BhyFoaXOL1Mb5p5OAWE6nuh8oGimo3sM2A8wmMNT8qgDF_HZ-V2T758-ftt8zm5ut9ebDzeZEUVZZBXknaqhMlyWqqlLaA2DopN52RZVpUqUaIoSWFU03HQITSsksLaBVLkqDRZr8uq0dwz-Z6ox6Z2NBp2DAf0ctaxUnriIZBQno0nVYsBOj8HuIBw0Z3phrxewegGrldBH9rpOsRfn_XOzw_YSOsNO-suzDjGx6UIqb-PFJnIhZCq6JvXJtrcOD_91Wl9_2d4WRYq-P0UxYby3GHQ06T8NtjYk7Lr19t8V_gI1v7RW</recordid><startdate>199410</startdate><enddate>199410</enddate><creator>Bonatz, G.</creator><creator>Lehmann-Willenbrock, E.</creator><creator>Kunstmann, P.</creator><creator>Semm, I.</creator><creator>Hedderich, J.</creator><creator>Semm, K.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199410</creationdate><title>Management of patients with persistent β-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy</title><author>Bonatz, G. ; Lehmann-Willenbrock, E. ; Kunstmann, P. ; Semm, I. ; Hedderich, J. ; Semm, K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4353-6a2f98a6c1759b85adc0a3f725d36695e7ec35a063b1cfeabd47a0dba71165ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Biological and medical sciences</topic><topic>Chorionic Gonadotropin - blood</topic><topic>Chorionic Gonadotropin, beta Subunit, Human</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Ectopic pregnancy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Laparoscopy</topic><topic>Local drug instillation</topic><topic>Medical sciences</topic><topic>Methotrexate - therapeutic use</topic><topic>Minimal invasive surgery</topic><topic>Ornipressin - therapeutic use</topic><topic>Peptide Fragments - blood</topic><topic>Pregnancy</topic><topic>Pregnancy, Tubal - blood</topic><topic>Pregnancy, Tubal - epidemiology</topic><topic>Pregnancy, Tubal - therapy</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Reoperation</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>Tubal-preserving treatment</topic><topic>β-hCG persistence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonatz, G.</creatorcontrib><creatorcontrib>Lehmann-Willenbrock, E.</creatorcontrib><creatorcontrib>Kunstmann, P.</creatorcontrib><creatorcontrib>Semm, I.</creatorcontrib><creatorcontrib>Hedderich, J.</creatorcontrib><creatorcontrib>Semm, K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonatz, G.</au><au>Lehmann-Willenbrock, E.</au><au>Kunstmann, P.</au><au>Semm, I.</au><au>Hedderich, J.</au><au>Semm, K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of patients with persistent β-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy</atitle><jtitle>International journal of gynecology and obstetrics</jtitle><addtitle>Int J Gynaecol Obstet</addtitle><date>1994-10</date><risdate>1994</risdate><volume>47</volume><issue>1</issue><spage>33</spage><epage>38</epage><pages>33-38</pages><issn>0020-7292</issn><eissn>1879-3479</eissn><coden>IJGOAL</coden><abstract>Objectives: To show that the β-human chorionic gonadotropin (hCG) decline following tubal-preserving techniques for ectopic pregnancy (EP) can take a longer course than currently believed, indicating expectant management; and to define the indications for a second-look laparoscopy if β-hCG persists.
Methods: Three hundred thirty-seven patients treated for EP were retrospectively reviewed. In order to define the ‘normal’ β-hCG decline following tubal-preserving techniques we acquired a Kaplan-Meier curve for 98 patients treated by laparoscopic linear salpingotomy, the main method performed for EP (253 patients). The Mann-Whitney U-test served as a statistical test. The patient population requiring a second-look laparoscopy for proliferating trophoblastic remnants is described.
Results: Twenty-eight patients (8.3%) required a second-look laparoscopy (acute abdominal pain and sonographically suspect findings combined with increasing β-hCG values). The majority (15 patients) underwent a preceding laparoscopic linear salpingotomy (6.5% unresolved cases). The relative β-hCG values differed significantly from the unresolved group compared to the group with resolved EP starting at postoperative day 2 (
P < 0.01). A maximal β-hCG decline period of 77 days postoperatively was observed.
Conclusions: Patients with slowly declining β-hCG levels following tubal-preserving techniques for EP can be managed expectantly. Increasing β-hCG values combined with abdominal pain and sonographically suspect observations indicate a second-look laparoscopy.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>7529199</pmid><doi>10.1016/0020-7292(94)90458-8</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7292 |
ispartof | International journal of gynecology and obstetrics, 1994-10, Vol.47 (1), p.33-38 |
issn | 0020-7292 1879-3479 |
language | eng |
recordid | cdi_proquest_miscellaneous_76925294 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Chorionic Gonadotropin - blood Chorionic Gonadotropin, beta Subunit, Human Diseases of mother, fetus and pregnancy Ectopic pregnancy Female Follow-Up Studies Gynecology. Andrology. Obstetrics Humans Laparoscopy Local drug instillation Medical sciences Methotrexate - therapeutic use Minimal invasive surgery Ornipressin - therapeutic use Peptide Fragments - blood Pregnancy Pregnancy, Tubal - blood Pregnancy, Tubal - epidemiology Pregnancy, Tubal - therapy Pregnancy. Fetus. Placenta Reoperation Retrospective Studies Time Factors Tubal-preserving treatment β-hCG persistence |
title | Management of patients with persistent β-hCG values following laparoscopic surgical and local drug treatment for ectopic pregnancy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T14%3A12%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20patients%20with%20persistent%20%CE%B2-hCG%20values%20following%20laparoscopic%20surgical%20and%20local%20drug%20treatment%20for%20ectopic%20pregnancy&rft.jtitle=International%20journal%20of%20gynecology%20and%20obstetrics&rft.au=Bonatz,%20G.&rft.date=1994-10&rft.volume=47&rft.issue=1&rft.spage=33&rft.epage=38&rft.pages=33-38&rft.issn=0020-7292&rft.eissn=1879-3479&rft.coden=IJGOAL&rft_id=info:doi/10.1016/0020-7292(94)90458-8&rft_dat=%3Cproquest_cross%3E76925294%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76925294&rft_id=info:pmid/7529199&rft_els_id=0020729294904588&rfr_iscdi=true |